$PATH

Ramani Hitesh sold $831K of PATH

Ramani Hitesh (Chief Accounting Officer) sold 50,000 shares of UiPath, Inc. (PATH) at an average of $16.62 ($16.50–$16.75, $0.83M total) across 2 trades over 2026-08-13 to 2026-08-14 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Ramani Hitesh
Published Aug 14, 2026, 8:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 14, 2026, 8:49 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PATH
Neutral
high confidence
Mentioned
$PATH
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PATHNeutralLow
01

Why it matters

The only new information is the disclosed sale size, timing, and price range, plus confirmation that it was executed under a pre-arranged 10b5-1 plan. No operational or financial guidance changes are included.

02

Market read

Traders may note insider selling, but the 10b5-1 structure and lack of fundamental updates make this more of a sentiment datapoint than a catalyst.

03

What to watch

The filing does not indicate whether additional sales occurred outside the disclosed window, nor does it provide context on total planned sales or remaining tranche size.

Relevance 4/10Novelty 5/10Timing: Filed on 2026-08-14 after two sales on 2026-08-13 and 2026-08-14.

Background

The article is a SEC Form 4 insider transaction disclosure for UiPath, Inc. (PATH) by Chief Accounting Officer Ramani Hitesh.

Company-level read

Ticker impact

$PATHNeutralHigh confidence
Context

UiPath Form 4 shows CFO Ramani Hitesh sold 50,000 shares in open-market trades at about $16.50 to $16.75 (10b5-1).

Expected impact

Low near-term impact; any reaction is likely limited to short-lived sentiment rather than a durable repricing.

Evidence & confidence

The filing is a routine Form 4 open-market sale by an officer, explicitly under a pre-arranged 10b5-1 plan, with no accompanying guidance, operational change, or regulatory/legal event disclosed.

Market effects

Minimal. Insider selling under 10b5-1 in a single software name does not materially change sector fundamentals.

Minimal.

Minimal.

Counterpoint

Because the trades are under a 10b5-1 plan, the sale may reflect scheduled liquidity rather than bearish expectations, so any negative read-through may be overstated.

Key entities

  • UiPath, Inc.

    Subject of the Form 4 insider sale disclosure.

  • Ramani Hitesh

    Chief Accounting Officer who sold shares via open-market trades under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PATHMed

A Philippine Telecom’s AI Makeover Tests UiPath’s (PATH) Pitch

UiPath (PATH) announced that PLDT, a Philippine telecom, scaled its use of UiPath's AI platform, improving efficiency and saving thousands of work hours. PATH reported Q2 2027 revenue of $410M, up 13% YoY, and annual recurring revenue of $1.938B, up 12%. The company also introduced new products and reshuffled its executive team. PATH's net new ARR was $37M, and GAAP operating income was $32M, below non-GAAP figures.

$PATHHigh

UiPath (PATH) Stock: Jump as Gartner Recognizes IDP Leadership

UiPath (PATH) stock rose 7.53% to $14.78 after Gartner named it a Leader in Intelligent Document Processing for the second year. The recognition highlights UiPath's role in enterprise automation and document management, with its IXP platform converting complex documents into structured data for workflows.

$PATHMedAI 8/10

UiPath Stock Rises 2.2%—Why Its 89% AI Survey Result Isn’t Revenue Yet

UiPath (PATH) shares rose 2.21% to $13.87 on Thursday, though still down 23.9% from pre-earnings levels. A company-sponsored survey showed 89% of respondents with embedded orchestration met ROI expectations, but this doesn't guarantee revenue growth. Q2 revenue increased 13% to $410M, with ARR up 12% to $1.938B. Management expects Q3 ARR of $1.992B-$1.997B. Investors await evidence of monetization at Investor Day on September 22.

$PATHHigh

Citi Just Upgraded UiPath Stock. Here's Why.

Citi's Yitchuin Wong upgraded UiPath (PATH) to 'Buy' with a $23 price target, citing its AI orchestration role and 60% upside potential. PATH stock has fallen 25% year-to-date after missing Q3 revenue estimates, but Wong sees long-term value in its AI integration and raised full-year revenue outlook to $1.789B, exceeding Zacks' consensus.